Olema Pharmaceuticals, Inc. (OLMA) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $48.30M | -65.4% |
| 2024 | $139.48M | +103.5% |
| 2023 | $68.54M | +189.2% |
| 2022 | $23.70M | +71.6% |
| 2021 | $13.81M | -95.9% |
| 2020 | $338.55M | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $48.30M | -65.4% |
| 2024 | $139.48M | +103.5% |
| 2023 | $68.54M | +189.2% |
| 2022 | $23.70M | +71.6% |
| 2021 | $13.81M | -95.9% |
| 2020 | $338.55M | — |